117.65
-1.61
(-1.35%)
As of 11:07:15 AM GMT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,411,819.00
2,411,819.00
2,320,785.00
2,021,903.00
1,425,851.00
Cost of Revenue
624,554.00
624,554.00
566,049.00
481,880.00
396,073.00
Gross Profit
1,787,265.00
1,787,265.00
1,754,736.00
1,540,023.00
1,029,778.00
Operating Expense
1,376,293.00
1,376,293.00
1,219,386.00
1,003,515.00
878,103.00
Operating Income
410,972.00
410,972.00
535,350.00
536,508.00
151,675.00
Net Non Operating Interest Income Expense
-11,535.00
-11,535.00
-14,612.00
-14,779.00
-14,166.00
Pretax Income
345,621.00
345,621.00
498,435.00
477,385.00
113,907.00
Tax Provision
98,811.00
98,811.00
63,655.00
78,099.00
21,640.00
Net Income Common Stockholders
246,072.00
246,072.00
434,789.00
396,079.00
91,282.00
Diluted NI Available to Com Stockholders
246,072.00
246,072.00
434,789.00
396,079.00
91,282.00
Basic EPS
1.54
--
2.73
2.49
0.57
Diluted EPS
1.54
--
2.72
2.48
0.57
Basic Average Shares
159,396.81
--
159,314.48
159,067.73
158,831.02
Diluted Average Shares
159,603.31
--
159,571.51
159,592.27
159,248.30
Total Operating Income as Reported
410,973.00
410,973.00
535,350.00
542,579.00
156,541.00
Total Expenses
2,000,847.00
2,000,847.00
1,785,435.00
1,485,395.00
1,274,176.00
Net Income from Continuing & Discontinued Operation
246,072.00
246,072.00
434,789.00
396,079.00
91,282.00
Normalized Income
248,157.59
248,157.59
435,755.18
437,962.60
103,469.26
Interest Income
6,783.00
6,783.00
2,577.00
2,258.00
1,460.00
Interest Expense
18,318.00
18,318.00
17,189.00
17,037.00
15,626.00
Net Interest Income
-11,535.00
-11,535.00
-14,612.00
-14,779.00
-14,166.00
EBIT
363,939.00
363,939.00
515,624.00
494,422.00
129,533.00
EBITDA
494,172.00
494,172.00
678,329.00
597,628.00
229,000.00
Reconciled Cost of Revenue
624,554.00
624,554.00
566,049.00
481,880.00
396,073.00
Reconciled Depreciation
130,233.00
130,233.00
162,705.00
103,206.00
99,467.00
Net Income from Continuing Operation Net Minority Interest
246,072.00
246,072.00
434,789.00
396,079.00
91,282.00
Total Unusual Items Excluding Goodwill
-2,921.00
-2,921.00
-1,108.00
-50,100.00
-15,046.00
Total Unusual Items
-2,921.00
-2,921.00
-1,108.00
-50,100.00
-15,046.00
Normalized EBITDA
497,093.00
497,093.00
679,437.00
647,728.00
244,046.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-835.41
-835.41
-141.82
-8,216.40
-2,858.74
12/31/2020 - 10/6/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FIE.F Fielmann Group AG
41.25
-0.36%
YPSNz.XC
FIE.BE Fielmann AG
41.05
-1.68%
UTMD Utah Medical Products, Inc.
60.91
-0.02%
YPSN.SW Ypsomed Holding AG
336.00
-0.88%
TECN.SW Tecan Group AG
221.20
-0.98%
WST West Pharmaceutical Services, Inc.
331.73
-1.54%
AFX.DE Carl Zeiss Meditec AG
46.12
-1.79%
BLCO Bausch + Lomb Corporation
17.76
-1.77%
ALC Alcon Inc.
83.41
-0.36%